Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 4066 AL 4080

Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis

Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, Cuzzocrea S, Zappia M, Giordano J, Calabrese EJ, Franceschi C.

Free Radic Biol Med. 2018 Feb 1;115:80-91. doi: 10.1016/j.freeradbiomed.2017.10.379. Epub 2017 Nov 25.

The prodromal microbiome

Scheperjans F.

Mov Disord. 2018 Jan;33(1):5-7. doi: 10.1002/mds.27197. Epub 2017 Oct 30.

Mitochondrial retrograde signaling in the nervous system

Hunt RJ, Bateman JM.

FEBS Lett. 2018 Mar;592(5):663-678. doi: 10.1002/1873-3468.12890. Epub 2017 Nov 12.

Deep brain stimulation in parkinsonian patients with dopa intolerance

García-Ruiz PJ, Feliz-Feliz C, Ayerbe Gracia J, Matías Arbelo J, Salvador C, Val Fernández JD, García-Caldentey J.

Neurocirugia (Engl Ed). 2018 Jul-Aug;29(4):213-215. doi: 10.1016/j.neucir.2017.09.005. Epub 2017 Oct 28.

Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need

Martinez-Martin P, Ray Chaudhuri K.

Expert Rev Neurother. 2018 Jan;18(1):41-50. doi: 10.1080/14737175.2018.1400383. Epub 2017 Nov 7.

Anterior cingulate cortex as an element of a possible novel motor circuit of the basal ganglia

Shin C, Kwon YN, Lee D, Hong IK, Kim HG, Lee KM, Ahn TB.

Parkinsonism Relat Disord. 2018 Jan;46:90-91. doi: 10.1016/j.parkreldis.2017.10.018. Epub 2017 Oct 26.

MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies

Liu L, Zhang L, Guo L, Yu Q, Li H, Teng J, Xie A.

Neurosci Lett. 2018 Jan 1;662:339-345. doi: 10.1016/j.neulet.2017.10.060. Epub 2017 Oct 31.

The pathophysiological mechanisms of motivational deficits in Parkinson's disease

Chagraoui A, Boukhzar L, Thibaut F, Anouar Y, Maltête D.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:138-152. doi: 10.1016/j.pnpbp.2017.10.022. Epub 2017 Oct 31.

Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed

Citrome L, Norton JC, Chi-Burris K, Demos G.

CNS Spectr. 2018 Jun;23(3):228-238. doi: 10.1017/S1092852917000736. Epub 2017 Nov 3.

Order and disorder in the physiological membrane binding of α-synuclein

Fusco G, Sanz-Hernandez M, De Simone A.

Curr Opin Struct Biol. 2018 Feb;48:49-57. doi: 10.1016/j.sbi.2017.09.004. Epub 2017 Nov 5.

REM sleep behavior disorder portends poor prognosis in Parkinson's disease: A systematic review

Kim Y, Kim YE, Park EO, Shin CW, Kim HJ, Jeon B.

J Clin Neurosci. 2018 Jan;47:6-13. doi: 10.1016/j.jocn.2017.09.019. Epub 2017 Nov 6.

What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders?

Kasahara T, Kato T.

Biol Psychiatry. 2018 May 1;83(9):731-738. doi: 10.1016/j.biopsych.2017.09.010. Epub 2017 Sep 21.

Current and future uses of transcranial focused ultrasound in neurosurgery

Hersh DS, Eisenberg HM.

J Neurosurg Sci. 2018 Apr;62(2):203-213. doi: 10.23736/S0390-5616.17.04230-8. Epub 2017 Nov 3.

Frontotemporal lobar degeneration due to P301L tau mutation showing apathy and severe frontal atrophy but lacking other behavioral changes: A case report and literature review

Miki T, Yokota O, Takenoshita S, Mori Y, Yamazaki K, Ozaki Y, Ueno SI, Haraguchi T, Ishizu H, Kuroda S, Terada S, Yamada N.

Neuropathology. 2018 Jun;38(3):268-280. doi: 10.1111/neup.12441. Epub 2017 Nov 6.

Diagnosis of multiple system atrophy

Palma JA, Norcliffe-Kaufmann L, Kaufmann H.

Auton Neurosci. 2018 May;211:15-25. doi: 10.1016/j.autneu.2017.10.007. Epub 2017 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias